Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study

Franco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, Virginie Gandemer, Fanny Rialland, Maura Faraci, Yoshiyuki Takahashi, Katsuyoshi Koh, Henrique Bittencourt, Grace Cleary, Christine Rosko, Xuechan Li, Annie St Pierre, Anirudh Prahallad, Cristina Diaz-de-Heredia

Blood (2024) 144 (20): 2095–2106.

https://doi.org/10.1182/blood.2023022565

Published: 2024

Includes: Supplemental data

Journal Articles

Diagnosing and Staging Central Nervous System Involvement in Pediatric ALL: A Global Survey on Its Heterogeneity

Laura Almási, Cornelia Eckert, Maria Thastrup, Vera Münch, Dániel Maszárovics, Bernadett Hon-Balla, Lennart Lenk, Gábor Barna, Wenyu Yang, Mignon L. Loh, Hyoung Jin Kang, Sophia Polychronopoulou, Arja Harila, Marko Kavcic, Kjeld Schmiegelow, Lüder Hinrich Meyer, Christina Halsey, Daniel J Erdelyi

Blood (2024) 144 (Supplement 1): 2805.

https://doi.org/10.1182/blood-2024-201255

Published: 2024

Journal Articles

Glofitamab in Combination with R-ICE Chemoimmunotherapy or as Monotherapy in Children and Adolescents with Relapsed/Refractory B-cell non-Hodgkin Lymphoma: Initial Safety and Efficacy Results from the Ongoing iMATRIX-GLO Study

Véronique Minard-Colin, Maitane Andión Catalán, Luciana Vinti, Hyoung Jin Kang, Nora Rahmani, Katia Gamel, Jade Wulff, Saibah Chohan, Raluca Negricea, Beate Wulff, Birgit Burkhardt

Blood (2024) 144 (Supplement 1): 6483.

https://doi.org/10.1182/blood-2024-194331

Published: 2024

Journal Articles

Outcome of Allogenic Hematopoietic Stem Cell Transplantation in Leukodystrophies: A Single-Center Experience over 15 Years

Hyun Jin Park, Jung Yoon Choi, Kyung Taek Hong, Bo Kyung Kim, Juyeon Lee, Yoon Sunwoo, Jong-Hee Chae, Byung Chan Lim, Hyoung Jin Kang

Blood (2024) 144 (Supplement 1): 7429.

https://doi.org/10.1182/blood-2024-201341

Published: 2024

Journal Articles

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Blood (2024) 144 (1): 35–45.

https://doi.org/10.1182/blood.2023022658

Published: 2024

Includes: Supplemental data

Journal Articles

A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real World Data

Yoona Choi, Bo Kyung Kim, Jae Won Yoo, Wona Choi, Jung-Hyun Won, Surin Jung, Jae Yoon Kim, In Young Choi, Nack-Gyun Chung, Jae Wook Lee, Hyoung Jin Kang, Howard Lee

Blood (2023) 142 (Supplement 1): 3791.

https://doi.org/10.1182/blood-2023-185435

Published: 2023

Journal Articles

Results of a Prospective Phase II Study of Individualized 6-Mercaptopurine Dosing Based on Pharmacogenomics in Childhood Acute Lymphoblastic Leukemia in East Asia

Hyery Kim, Jung Yoon Choi, Sung Han Kang, Kyung Nam Koh, Kyung Taek Hong, Hee Young Ju, Keon Hee Yoo, Sunmin Yun, Yoomi Park, Ju Han Kim, Hyoung Jin Kang, Ho Joon Im

Blood (2023) 142 (Supplement 1): 1497.

https://doi.org/10.1182/blood-2023-189987

Published: 2023

Journal Articles

Prospective Phase II Study of HSCT Using Targeted Busulfan, Fludarabine, Etoposide Conditioning for Pediatric ALL

Kyung Taek Hong, Hyun Jin Park, Bo Kyung Kim, Hong Yul An, Jung Yoon Choi, Hyoung Jin Kang

Blood (2022) 140 (Supplement 1): 4716–4717.

https://doi.org/10.1182/blood-2022-165559

Published: 2022

Journal Articles

Ruxolitinib in Pediatric Patients with Treatment- Naïve or Steroid-Refractory Acute Graft-Versus-Host Disease: Primary Findings from the Phase I/II REACH4 Study

Franco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, Virginie Gandemer, Fanny Rialland, Maura Faraci, Yoshiyuki Takahashi, Katsuyoshi Koh, Henrique Bittencourt, Grace Cleary, Christine Rosko, Pantelia Roussou, Annie St. Pierre, Anirudh Prahallad, Cristina Díaz-de-Heredia

Blood (2022) 140 (Supplement 1): 1376–1378.

https://doi.org/10.1182/blood-2022-155708

Published: 2022

Journal Articles

Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome

Blood (2021) 138 (21): 2117–2128.

https://doi.org/10.1182/blood.2021010913

Published: 2021

Includes: Supplemental data

Journal Articles

Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

Blood (2021) 138 (Supplement 1): 4310.

https://doi.org/10.1182/blood-2021-153346

Published: 2021

Journal Articles

Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis

Blood (2021) 138 (Supplement 1): 516.

https://doi.org/10.1182/blood-2021-150272

Published: 2021

Journal Articles

Posttransplant Cyclophosphamide-Based Haploidentical Vs Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia

Kyung Taek Hong, Hyun Jin Park, Bo Kyung Kim, Hong Yul An, Jung Yoon Choi, Hyoung Jin Kang

Blood (2021) 138 (Supplement 1): 2874.

https://doi.org/10.1182/blood-2021-150547

Published: 2021

Journal Articles

A Phase 3, Randomized, Adaptive Study of Defibrotide (DF) Vs Best Supportive Care (BSC) for the Prevention of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) in Patients (pts) Undergoing Hematopoietic Cell Transplantation (HCT): Preliminary Results

Stephan A. Grupp, Selim Corbacioglu, Hyoung Jin Kang, Takanori Teshima, Michelle Zanette, Paty Lopez, Vian Amber, Antonio Pagliuca, Paul G. Richardson

Blood (2021) 138 (Supplement 1): 749.

https://doi.org/10.1182/blood-2021-147284

Published: 2021

Journal Articles

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Blood (2019) 134 (23): 2036–2045.

https://doi.org/10.1182/blood.2019000069

Published: 2019

Includes: Supplemental data

Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3594.

https://doi.org/10.1182/blood-2019-125266

Published: 2019

Journal Articles

Immunosenescent Characteristics of T Cells in Young Patients Following Haploidentical Stem Cell Transplantation from Parental Donors

Ga Hye Lee, Kyung Taek Hong, MD, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Won-Woo Lee, PhD DVM, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3283.

https://doi.org/10.1182/blood-2019-125282

Published: 2019

Journal Articles

Comparison of Haploidentical Transplantation with Post-Transplantation Cyclophosphamide and Umbilical Cord Blood Transplantation in Children and Adolescents with Hematologic Malignancies after Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring

Kyung Taek Hong, MD, Hyoung Jin Kang, MD PhD, Hong Yul Ahn, MD, Jung Yoon Choi, MD, Sang Hoon Song, MD PhD, Kyung-Sang Yu, MD PhD, In-Jin Jang, MD PhD, Hee Young Shin, MD PhD

Blood (2018) 132 (Supplement 1): 2163.

https://doi.org/10.1182/blood-2018-99-112090

Published: 2018

Journal Articles

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Jung Yoon Choi, MD, Heewon Seo, Yoomi Park, ByungJoo Min, Hyery Kim, MD, Kyung Taek Hong, MD, Che Ry Hong, MD, Sang Hoon Song, MD, Kyung-Sang Yu, MD, In-Jin Jang, MD, Kyung Duk Park, MD, Hee Young Shin, MD, Ju Han Kim, MD, Hyoung Jin Kang, MD

Blood (2017) 130 (Supplement 1): 1963.

https://doi.org/10.1182/blood.V130.Suppl_1.1963.1963

Published: 2017

Journal Articles

Hematopoietic, Immune Recovery and Outcomes after Autologous Stem Cell Transplantation Following Plerixafor Plus G-CSF Versus Chemotherapy and G-CSF Based Mobilization in Pediatric Patients

Jung Yoon Choi, MD, Hyoung Jin Kang, MD, Kyung Taek Hong, MD, Che Ry Hong, MD, Kyung Duk Park, MD, Hee Young Shin, MD

Blood (2017) 130 (Supplement 1): 2020.

https://doi.org/10.1182/blood.V130.Suppl_1.2020.2020

Published: 2017

NARROW

Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study

Diagnosing and Staging Central Nervous System Involvement in Pediatric ALL: A Global Survey on Its Heterogeneity

Glofitamab in Combination with R-ICE Chemoimmunotherapy or as Monotherapy in Children and Adolescents with Relapsed/Refractory B-cell non-Hodgkin Lymphoma: Initial Safety and Efficacy Results from the Ongoing iMATRIX-GLO Study

Outcome of Allogenic Hematopoietic Stem Cell Transplantation in Leukodystrophies: A Single-Center Experience over 15 Years

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real World Data

Results of a Prospective Phase II Study of Individualized 6-Mercaptopurine Dosing Based on Pharmacogenomics in Childhood Acute Lymphoblastic Leukemia in East Asia

Prospective Phase II Study of HSCT Using Targeted Busulfan, Fludarabine, Etoposide Conditioning for Pediatric ALL

Ruxolitinib in Pediatric Patients with Treatment- Naïve or Steroid-Refractory Acute Graft-Versus-Host Disease: Primary Findings from the Phase I/II REACH4 Study

Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome

Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis

Posttransplant Cyclophosphamide-Based Haploidentical Vs Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia

A Phase 3, Randomized, Adaptive Study of Defibrotide (DF) Vs Best Supportive Care (BSC) for the Prevention of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) in Patients (pts) Undergoing Hematopoietic Cell Transplantation (HCT): Preliminary Results

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Immunosenescent Characteristics of T Cells in Young Patients Following Haploidentical Stem Cell Transplantation from Parental Donors

Comparison of Haploidentical Transplantation with Post-Transplantation Cyclophosphamide and Umbilical Cord Blood Transplantation in Children and Adolescents with Hematologic Malignancies after Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Hematopoietic, Immune Recovery and Outcomes after Autologous Stem Cell Transplantation Following Plerixafor Plus G-CSF Versus Chemotherapy and G-CSF Based Mobilization in Pediatric Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only